A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 109.50
GOOG 639.16
MSFT 47.45
FB 92.47
BAC 15.75

Recently Added

MHK 197.52
HLS 38.61
LB 96.53
TERP 19.81
SUNE 9.16

Gaining Speed

HLS 38.61
MHK 197.52
LB 96.53
AZO 735.31
VLDI 0.04

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!